Effectiveness of a Fenofibrate 145-mg Nanoparticle Tablet Formulation Compared with the Standard 160-mg Tablet in Patients with Coronary Heart Disease and Dyslipidemia-Reference-Cited by-同舟云学术

Effectiveness of a Fenofibrate 145-mg Nanoparticle Tablet Formulation Compared with the Standard 160-mg Tablet in Patients with Coronary Heart Disease and Dyslipidemia

Published:2008-05 Issue:5 Volume:28 Page:570-575
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Maciejewski Stephanie,Hilleman Daniel

Publisher

Wiley

Subject

Pharmacology (medical)

Reference16 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

3. Epidemiology of triglycerides: A view from Framingham

4. The Complex Role of Triglycerides in Cardiovascular Disease

5. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic;Heliyon;2023-04

2. UV–visible absorption spectroscopy for in-line API concentration measurement in nanoparticle production process using controlled expansion of supercritical solutions (CESS®);Journal of Pharmaceutical and Biomedical Analysis;2023-02

3. Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study;eLife;2023-01-27

4. Association of Pericardiac Adipose Tissue With Coronary Artery Disease;Frontiers in Endocrinology;2021-09-06

5. Dissolution/permeation: The importance of the experimental setup for the prediction of formulation effects on fenofibrate in vivo performance;PHARMAZIE;2017